EMIT Imaging

EMIT Imaging

生物技术研究

Baltimore,Maryland 2,196 位关注者

Industry-leading CFT instrument & services provider: 3D imaging tool to monitor drug distribution and protein expression

关于我们

Cryo-Fluorescence Tomography (CFT) is a novel, 3D approach to imaging drug distribution and protein expression in whole animals and large tissue samples. EMIT Imaging offers both instrumentation and services via our imaging platform, XerraTM, a high-resolution, high-sensitivity preclinical imaging tool designed to advance discoveries in biological and drug research. See what you’re missing with standard 2D in vivo fluorescence imaging techniques and utilize CFT to better visualize: - Whole-body drug distribution and delivery - Screening candidate drugs and delivery systems - Whole-body therapeutic protein expression - Multiplexed co-localization of drug with targets - On and off target tissue identification

网站
https://www.emitimaging.com
所属行业
生物技术研究
规模
11-50 人
总部
Baltimore,Maryland
类型
私人持股
创立
2018
领域
Molecular Tissue Imaging、Cryo-Fluorescence Tomography、Mesoscopic、Automated Tissue Imaging、Gene Therapy、Oncology、Drug Discovery、Research、Cell Therapy、Immunotherapy、Drug Development、Fluorescence、Drug Delivery、PK/PD、Preclinical Imaging、Xerra和CFT Services

地点

  • 主要

    875 Hollins St

    US,Maryland,Baltimore,21201

    获取路线

EMIT Imaging员工

动态

相似主页

查看职位

融资

EMIT Imaging 共 3 轮

上一轮

未知

US$5,324,460.00

Crunchbase 上查看更多信息